Anti-Obesity Drugs

William J. Houlihan

Found an issue? Give us feedback

https://doi.org/10.1...arrow_drop_down

https://doi.org/10.1002/143560...

Part of book or chapter of book . 2000 . Peer-reviewed

Data sources: Crossref

https://dx.doi.org/10.1002/143...

Other literature type

Data sources: Microsoft Academic Graph

Anti-Obesity Drugs

descriptionPublicationkeyboard_double_arrow_right Part of book or chapter of book , Other literature type 15 Jun 2000 English Publisher:Wiley-VCH Verlag GmbH & Co. KGaA

Authors: William J. Houlihan;

doi: 10.1002/14356007.a02_313

Anti-Obesity Drugs

- Summary
- Metrics

Abstract

The article contains sections titled: 1. Introduction 2. Animal and Human Test Procedures 3. Mechanism of Action 4. Clinical Side Effects 5. Phenethylamine Derivatives 5.1. β-Phenylisopropylamines 5.2. β-Phenyl-tert-butylamines 5.3. β-Phenyl-β-oxyisopropylamines 5.4. 1-Methyl-2-phenylmorpholines 6. Other Compounds 7. Economic Aspects

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average